| Safe Drinking Levels |
| > No safe threshold for maternal alcohol intake. > Abstinence is recommended during pregnancy > Women can be reassured that adverse fetal effects have not been demonstrated with mild social drinking before realizing they were pregnant |
| Screening and Identification | > Ask about number of standard drinks per day and per week. > 1 standard drink = 1 bottle beer, 5 oz wine, 1 1/2 ounce liquor > Ask about maximum consumption on any 1 day since pregnancy began. > Order GGT and MCV if alcohol use suspected (sensitivity 50% for 4 or more drinks per day)
|
| Symptoms and Signs of Withdrawal |
| > Common in women drinking 6 or more drinks per day > Onset 8-12 hours after last drink, peaks 24-72 hours, may last 7 days > Tremor (postural, intention), ataxia, sweating are most reliable signs > Other signs: hypertension, tachycardia, gastrointestinal upset, anxiety > Complications: seizures (grand-mal, non-focal, brief), hallucinations, arrhythmias, delirium tremens |
| Management of Withdrawal |
| > Admit to hospital > Monitor hydration status and rule out electrolyte imbalance > Monitor for non-reassuring fetal status > Folic acid 5mg po od > Thiamine 100 mg po od x 3 days > If not in labour, treat with diazepam 20 mg po q 1-2 h until minimal tremor; ongoing treatment not usually needed During labour: > Notify neonatology/paediatrics: benzodiazepines can cause "floppy baby syndrome" > Use lorazepam 2-4 mg sl, po q 2-4 h prn |
| Fetal Effects |
| Fetal Alcohol Spectrum Disorder (FASD) Includes Fetal Alcohol Syndrome and other alcohol-related birth defects and neurological disorders Prevalence of Fetal Alcohol Spectrum Disorder: ~1 in 100 live births Prevalence of Fetal Alcohol Syndrome: ~1 in 1000 live births (general population): 4-5% in heavy drinkers Features of FAS include: > Growth restriction > Characteristic facial anomalies, e.g., microcephaly,micrognathia, short palpebral fissure, flat philtrum > Central nervous system abnormalities, developmental delays, brain malformations, intellectual impairment, behavioural problems > See guideline on diagnosing FASD in CMAJ 2005; 172 (5suppl.): S1-S21 (www.cmaj.ca) Other complications of alcohol: > Spontaneous abortion > Fetal compromise |
| Neonatal Effects |
| > If mother intoxicated at time of delivery, assess neonate for withdrawal |
| Breastfeeding |
| > Alcohol enters breast milk and infants are exposed to a fraction of the alcohol ingested by the mother > Potential adverse effects include: impaired motor development in child and decreased let-down reflex and suppressed lactation in mother > An acceptable level of alcohol in breast milk has not been established > With moderate, occasional alcohol use: delay nursing for 1-2 hours per drink to minimize infant exposure; heavy alcohol consumption while breastfeeding should be avoided while breastfeeding |
| Management of Alcohol Dependence |
| > Behavourial interventions recommended > Pharmacotherapy can help to maintain abstinence e.g., anti-craving (naltrexone and acamprosate) and aversive (disulfiram) agents |
| Anti-alcohol Drugs |
| > Disulfiram: acetaldehyde dehydrogenase inhibitor;teratogenic, contraindicated in pregnancy > Naltrexone: opioid receptor antagonist; safety not established in pregnancy; use only if behavioural treatment has failed and benefit outweighs risk > Acamprosate: glutamate modulator; safety not established in pregnancy, use not recommended in pregnancy |
